Guettner, Achim,Machacek, Matthias,Papavassilis, Charis,Sander, Oliver
申请号：
AU2011311482
公开号：
AU2011311482A1
申请日:
2011.10.07
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
The disclosure relates to novel regimens for treating psoriasis, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., an IL-17 binding molecule, e.g., an IL-17 antibody, such as the secukinumab antibody, or an IL-17 receptor binding molecule, e.g., an IL-17 receptor antibody.
